Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
In a phase 2 trial, 10-mg bulevirtide plus pegylated interferon alfa-2a was superior to bulevirtide alone with regard to an undetectable HDV RNA level...
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
In this phase 2 trial in patients with metabolic dysfunction–associated steatohepatitis and moderate or severe fibrosis, tirzepatide was more effective than placebo with respect...
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
In this phase 2 trial involving adults with metabolic dysfunction–associated steatohepatitis and liver fibrosis, survodutide was superior to placebo with respect to improvement in...
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
In this phase 2 trial involving adults with metabolic dysfunction–associated steatohepatitis and liver fibrosis, survodutide was superior to placebo with respect to improvement in...
